alpha-Ergocryptine
This page covers all alpha-Ergocryptine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 6, Cytochrome P450 2C9, 5-hydroxytryptamine receptor 1A.
Targets
5-hydroxytryptamine receptor 6, Cytochrome P450 2C9, 5-hydroxytryptamine receptor 1A
Patent intelligence
- alpha ergocryptine patent landscape — aggregated cliff calendar, attackable patents, originator estates